Annual Current Assets
$338.87 M
-$35.86 M-9.57%
December 31, 2023
Summary
- As of February 7, 2025, RVNC annual total current assets is $338.87 million, with the most recent change of -$35.86 million (-9.57%) on December 31, 2023.
- During the last 3 years, RVNC annual current assets has fallen by -$111.14 million (-24.70%).
- RVNC annual current assets is now -24.70% below its all-time high of $450.00 million, reached on December 31, 2020.
Performance
RVNC Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$329.69 M
-$20.48 M-5.85%
September 30, 2024
Summary
- As of February 7, 2025, RVNC quarterly total current assets is $329.69 million, with the most recent change of -$20.48 million (-5.85%) on September 30, 2024.
- Over the past year, RVNC quarterly current assets has dropped by -$58.83 million (-15.14%).
- RVNC quarterly current assets is now -36.41% below its all-time high of $518.44 million, reached on March 31, 2020.
Performance
RVNC Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
RVNC Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -9.6% | -15.1% |
| 3 y3 years | -24.7% | +12.2% |
| 5 y5 years | +63.0% | +49.5% |
RVNC Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -9.6% | +37.7% | -20.7% | +34.0% |
| 5 y | 5-year | -24.7% | +37.7% | -36.4% | +34.0% |
| alltime | all time | -24.7% | +6939.2% | -36.4% | >+9999.0% |
Revance Therapeutics Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $329.69 M(-5.8%) |
| Jun 2024 | - | $350.17 M(-5.3%) |
| Mar 2024 | - | $369.69 M(+9.1%) |
| Dec 2023 | $139.59 M(-32.6%) | $338.87 M(-12.8%) |
| Sep 2023 | - | $388.52 M(+2.5%) |
| Jun 2023 | - | $378.95 M(+17.3%) |
| Mar 2023 | - | $323.02 M(-13.8%) |
| Dec 2022 | $207.17 M(-27.3%) | $374.73 M(-9.8%) |
| Sep 2022 | - | $415.59 M(+59.3%) |
| Jun 2022 | - | $260.94 M(-8.5%) |
| Mar 2022 | - | $285.33 M(+15.9%) |
| Dec 2021 | $285.05 M(+5.5%) | $246.12 M(-16.3%) |
| Sep 2021 | - | $293.88 M(-17.1%) |
| Jun 2021 | - | $354.60 M(-12.8%) |
| Mar 2021 | - | $406.43 M(-9.7%) |
| Dec 2020 | $270.22 M(+518.6%) | $450.00 M(-0.0%) |
| Sep 2020 | - | $450.11 M(-10.5%) |
| Jun 2020 | - | $502.77 M(-3.0%) |
| Mar 2020 | - | $518.44 M(+74.8%) |
| Dec 2019 | $43.69 M(+137.1%) | $296.60 M(+34.5%) |
| Sep 2019 | - | $220.57 M(-11.7%) |
| Jun 2019 | - | $249.91 M(-9.8%) |
| Mar 2019 | - | $277.12 M(+33.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $18.43 M(+75.7%) | $207.92 M(-3.7%) |
| Sep 2018 | - | $215.88 M(-11.1%) |
| Jun 2018 | - | $242.88 M(-11.2%) |
| Mar 2018 | - | $273.42 M(-4.1%) |
| Dec 2017 | $10.49 M(-10.1%) | $285.21 M(+82.5%) |
| Sep 2017 | - | $156.27 M(-10.4%) |
| Jun 2017 | - | $174.35 M(-11.7%) |
| Mar 2017 | - | $197.45 M(+2.5%) |
| Dec 2016 | $11.66 M(-46.6%) | $192.69 M(-7.7%) |
| Sep 2016 | - | $208.68 M(-4.5%) |
| Jun 2016 | - | $218.56 M(-8.4%) |
| Mar 2016 | - | $238.49 M(-6.1%) |
| Dec 2015 | $21.86 M(+10.7%) | $253.96 M(+77.0%) |
| Sep 2015 | - | $143.50 M(+4.5%) |
| Jun 2015 | - | $137.26 M(-11.8%) |
| Mar 2015 | - | $155.69 M(-9.9%) |
| Dec 2014 | $19.74 M(+10.7%) | $172.73 M(-9.5%) |
| Sep 2014 | - | $190.91 M(-7.6%) |
| Jun 2014 | - | $206.56 M(+126.6%) |
| Mar 2014 | - | $91.17 M(+1793.9%) |
| Dec 2013 | $17.83 M(+122.4%) | $4.81 M(+58.9%) |
| Sep 2013 | - | $3.03 M(-43.9%) |
| Dec 2012 | $8.02 M(-18.3%) | $5.41 M |
| Dec 2011 | $9.81 M | - |
FAQ
- What is Revance Therapeutics annual total current assets?
- What is the all time high annual current assets for Revance Therapeutics?
- What is Revance Therapeutics annual current assets year-on-year change?
- What is Revance Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Revance Therapeutics?
- What is Revance Therapeutics quarterly current assets year-on-year change?
What is Revance Therapeutics annual total current assets?
The current annual current assets of RVNC is $338.87 M
What is the all time high annual current assets for Revance Therapeutics?
Revance Therapeutics all-time high annual total current assets is $450.00 M
What is Revance Therapeutics annual current assets year-on-year change?
Over the past year, RVNC annual total current assets has changed by -$35.86 M (-9.57%)
What is Revance Therapeutics quarterly total current assets?
The current quarterly current assets of RVNC is $329.69 M
What is the all time high quarterly current assets for Revance Therapeutics?
Revance Therapeutics all-time high quarterly total current assets is $518.44 M
What is Revance Therapeutics quarterly current assets year-on-year change?
Over the past year, RVNC quarterly total current assets has changed by -$58.83 M (-15.14%)